Iloperidone API is a pharmaceutical-grade atypical antipsychotic agent primarily indicated for the treatment of schizophrenia in adults. It acts by selectively antagonizing dopamine D₂ and serotonin 5-HT₂A receptors, helping restore neurotransmitter balance and improve symptoms such as hallucinations, delusions, disorganized thinking, and cognitive impairment.
Iloperidone is formulated into oral tablet formulations and is widely used in modern psychiatric treatment due to its efficacy in managing schizophrenia while offering a favorable tolerability profile.
Manufactured under WHO-GMP-certified facilities, our Iloperidone API provides exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive quality testing and is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Iloperidone API is used in pharmaceutical formulations for the treatment of schizophrenia and other psychiatric disorders as prescribed by healthcare professionals.
Iloperidone blocks dopamine D₂ and serotonin 5-HT₂A receptors in the brain, helping reduce psychotic symptoms and improve overall mental function.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every batch.
Yes. We supply Iloperidone API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp